Idiopathic Pulmonary Fibrosis Current Events | Idiopathic Pulmonary Fibrosis News | 2
|
| Page
2 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
Large clinical trial finds pirfenidone may help lung function in IPF patients
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF. view more (2009-05-18)
Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in
Family, friends and neighbors remember Lisa Sandler Spaeth as an active mother of two in Potomac, Md., with a lot on the go, juggling her son's baseball games and her daughter's horseback-riding lessons with numerous committee obligations, organizing women's activities at her local synagogue. view more (2008-07-30)
First different black/white mechanism in pulmonary fibrosis/scleroderma identified
Of the more than 40,000 persons who die each year in the U.S. from pulmonary fibrosis, the mortality rate among African-Americans is twice as high Caucasians. view more (2006-04-05)
Common antibacterial treatment linked to sensorineural hearing loss in cystic fibrosis patients
An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery. view more (2009-07-01)
The natural history of 'healthy-HCV carriers'
A normal liver is observed in about 10% of HCV infected patients and the natural history of theses so-called "healthy-HCV carriers" is not fully defined. view more (2008-09-24)
Cystic fibrosis testing -- next steps
Three reports describing advances in cystic fibrosis genetic testing appear in the May 2009 issue of The Journal of Molecular Diagnostics. view more (2009-04-28)
Antifibrotic effects of green tea
Several studies have shown that lipid peroxidation stimulates collagen production in fibroblasts and hepatic stellate cells (HSC), and plays an important role in the development of liver fibrosis. view more (2009-11-18)
Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C. view more (2009-05-18)
Antibiotic Could Offer Promise For Treatment Of Cystic Fibrosis
The antibiotic azithromycin could offer some benefit to people with cystic fibrosis if they do not respond to conventional treatment, suggest authors of a study in this week's issue of THE LANCET. Cystic fibrosis is a severe genetic disorder-the most commonly recessively inherited disorder in white populations. Treatment is limited, and aimed at... view more... (2002-09-25)
Tocilizumab study offers new hope for children with arthritis
A new study has confirmed significant improvements after treatment with tocilizumab amongst children with systemic juvenile idiopathic arthritis (sJIA), who do not tolerate or have an inadequate response to conventional therapies. view more (2006-06-23)
Gene mutations linked to hereditary lung disease
Scientists at Johns Hopkins have identified the genetic culprits that trigger a hereditary form of a fatal lung disease. The findings, published in the March 29, 2007 issue of the New England Journal of Medicine, may provide new directions in diagnosis and treatment for families that inherit genes for the disease, as well as for those that develop... view more... (2007-03-29)
p90RSK: A new therapeutic target for liver fibrosis?
Cirrhosis is a world wide, bad prognosis liver disease and characterized by excessive collagen deposition and liver function damage. view more (2009-05-13)
Liver fibrosis will be treated by a potential target
The outcome of hepatitis is either self recovery or its development into liver fibrosis or, further, liver cirrhosis. Liver fibrosis is the early pathological process of cirrhosis, which is considered a reversible, wound-healing response. Since no ideal drug is available for its therapy, liver fibrosis is currently considered to be a major... view more... (2007-10-17)
Heart catheters do not benefit patients
Doctors should probably stop using pulmonary artery catheters because they do not benefit patients, say doctors from Australia in this week's BMJ. view more (2006-11-03)
An effective strategy for inhibition of cirrhosis
In China, the incidence of liver cirrhosis is still high, although new therapeutic approaches have recently been proposed, there is no established therapy for liver fibrosis, and Authors investigated the prevention effects of Chinese Medicine Qianggan-Rongxian Soup on liver fibrosis induced by DMN in rat. view more (2008-09-25)
Pulmonary CT angiography identifies disease and injury beyond the pulmonary arteries in children
Computed tomography angiography (CTA) can identify abnormalities and injury beyond the pulmonary arteries, including broken bones and heart disease, according to a study published in the September issue of the American Journal of Roentgenology (AJR) view more (2009-08-19)
Breath test offers hope for early detection of lung-bacteria growth in cystic fibrosis
Breath-analysis testing may prove to be an effective, non-invasive method for detecting the damaging lung-bacteria growth seen in cystic fibrosis, which would allow for early stage treatments that can extend the health of people with this disease. view more (2005-10-18)
THE VALUE OF CYSTIC FIBROSIS SCREENING (p 789)
Research published in this week's issue of THE LANCET concludes that screening babies for cystic fibrosis provides the opportunity for more reliable prenatal diagnosis of the disease. The value of screening for the currently incurable disease cystic fibrosis has been the subject of debate over the past few years. Virginie Scotet and colleagues... view more... (2000-08-30)
Women with cystic fibrosis "too embarrassed" to seek help for incontinence
A study in this week's BMJ finds that over two-thirds of women with the chest disease cystic fibrosis suffer urinary incontinence, yet are reluctant to seek help. Given that incontinence can affect a patient's ability to perform essential daily treatment procedures, addressing this problem should become part of the routine management of cystic... view more... (2001-06-20)
Inhaled Antibiotic For Treatment Of Early Lung Infection In Patients With Cystic Fibrosis (p 983)
Inhalation of the antibiotic tobramycin could have an important future role in reducing lung infection of patients with cystic fibrosis, suggest authors of a research letter in this week's issue of THE LANCET. More than 80% of patients with cystic fibrosis are chronically infected by the bacterium Pseudomonas aeruginosa. Infection reduces lung... view more... (2001-09-19)
|
|
| Page
2 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
|
